SCHEMBL18762885

SCHEMBL18762885

COc1ccccc1Cc1cc(C(C)Cc2cc(C(C)C)cc(C(F)(F)F)n2)ccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASR P41180 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ EDNRB P24530 1/20 0.35
▸ EDNRA P25101 1/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ ALOX15 P16050 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13561353 0.81 HTR2C (0.45) ALDH1A1CYP3A4CYP2D6SLC6A2SLC6A4
SCHEMBL25499879 0.71 HSP90AA1 (0.35) CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL20674836 0.71 HSP90AA1 (0.34) CYP3A4CYP2D6TSHRHSD17B10CYP1A2
SCHEMBL19706482 0.70 MDM2 (0.37) CYP3A4CYP2D6ALOX15TSHRMAPK1
SCHEMBL26791964 0.70 LOXL2 (0.35) ALDH1A1CYP3A4CYP2D6
SCHEMBL13561346 0.67 ATM (0.43) CASRCYP3A4CYP2D6SLC6A2SLC6A4
SCHEMBL18542081 0.67 NPSR1 (0.62) ALDH1A1MAPK1HSD17B10KDM4ENPSR1
SCHEMBL13562428 0.67 NPC1 (0.48) TSHRMAPK1KDM4EHTR2CLMNA
SCHEMBL6754661 0.66 IDO1 (0.52) ALDH1A1CYP3A4CYP2D6TSHRCYP1A2
SCHEMBL21361203 0.65 RXRA (0.41) CASRALDH1A1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9751890-B2 Heteroaryl derivatives as CFTR modulators VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-09-05 — — US disclosed
US-20170107225-A1 HETEROARYL DERIVATIVES AS CFTR MODULATORS VERTEX PHARMACEUTICALS INCORPORATED 2017-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170107225-A1 HETEROARYL DERIVATIVES AS CFTR MODULATORS CFTR, ABCB1, ABCD3 CASR 1051/4885ALDH1A1 2397/4885EDNRB 1098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback